Hypermethylation of <i>RAD51L3</i> and <i>XRCC2</i> Genes to Predict Late Toxicity in Chemoradiotherapy-Treated Cervical Cancer Patients Cited by

Fol. Biol. 2013, 59, 240-245

https://doi.org/10.14712/fb2013059060240

Hypermethylation of RAD51L3 and XRCC2 Genes to Predict Late Toxicity in Chemoradiotherapy-Treated Cervical Cancer Patients

Simona Paulíková¹, M. Chmelařová², J. Petera¹, V. Palička², A. Paulík¹

¹Department of Oncology and Radiotherapy, Charles University in Prague – Faculty of Medicine in Hradec Králové and Faculty Hospital Hradec Králové, Czech Republic
²Department of Clinical Biochemistry and Diagnostics, Charles University in Prague – Faculty of Medicine in Hradec Králové and Faculty Hospital Hradec Králové, Czech Republic

Received August 2013
Accepted October 2013

Crossref Cited-by Linking

George Irene A., Chauhan Richa, Dhawale R.E., Iyer Roshini, Limaye Sewanti, Sankaranarayanan R., Venkataramanan R., Kumar Prashant: Insights into therapy resistance in cervical cancer. Advances in Cancer Biology - Metastasis 2022, 6, 100074. <https://doi.org/10.1016/j.adcanc.2022.100074>
Han Yang, Hu Xinting, Yun Xiaoya, Liu Jiarui, Yang Juan, Tian Zheng, Zhang Xin, Zhang Ya, Wang Xin: Nucleolar and spindle associated protein 1 enhances chemoresistance through DNA damage repair pathway in chronic lymphocytic leukemia by binding with RAD51. Cell Death Dis 2021, 12. <https://doi.org/10.1038/s41419-021-04368-2>
Romero-Garcia Susana, Prado-Garcia Heriberto, Carlos-Reyes Angeles: Role of DNA Methylation in the Resistance to Therapy in Solid Tumors. Front. Oncol. 2020, 10. <https://doi.org/10.3389/fonc.2020.01152>
Chen Techang, Li Xiaoqi, Ma Ning, Shan Jingbo, Guo Peiyan, Zhou Sa, Ma Wenjian, Xu Z.B., Chen D.Q., Liu J.Y.: Rad51 stabilizes the ends of two adjacent DSBs in yeast. E3S Web Conf. 2019, 131, 01013. <https://doi.org/10.1051/e3sconf/201913101013>
Chmelarova Marcela, Laco Jan, Kovarikova Helena, Baranova Ivana, Dundr Pavel, Nemejcova Kristyna, Michalek Jaroslav, Vosmik Milan, Palicka Vladimir: Elevated DNA methylation in malignant tumors of the sinonasal tract and its association with patient survival. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2018, 162, 232. <https://doi.org/10.5507/bp.2018.012>
Bhat Samatha, Kabekkodu Shama Prasada, Noronha Ashish, Satyamoorthy Kapaettu: Biological implications and therapeutic significance of DNA methylation regulated genes in cervical cancer. Biochimie 2016, 121, 298. <https://doi.org/10.1016/j.biochi.2015.12.018>
Herskind Carsten, Talbot Christopher J., Kerns Sarah L., Veldwijk Marlon R., Rosenstein Barry S., West Catharine M.L.: Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity?. Cancer Letters 2016, 382, 95. <https://doi.org/10.1016/j.canlet.2016.02.035>
Yin De-Tao, Xu Jianhui, Lei Mengyuan, Li Hongqiang, Wang Yongfei, Liu Zhen, Zhou Yubing, Xing Mingzhao: Characterization of the novel tumor-suppressor gene CCDC67 in papillary thyroid carcinoma. Oncotarget 2016, 7, 5830. <https://doi.org/10.18632/oncotarget.6709>
Nowacka-Zawisza Maria, Wi\u015bnik Ewelina, Wasilewski Andrzej, Skowro\u0144ska Milena, Forma Ewa, Bry\u015b Magdalena, Ró\u017ca\u0144ski Waldemar, Krajewska Wanda M.: Polymorphisms of Homologous RecombinationRAD51,RAD51B,XRCC2, andXRCC3Genes and the Risk of Prostate Cancer. Analytical Cellular Pathology 2015, 2015, 1. <https://doi.org/10.1155/2015/828646>
Qin Chang-Jiang, Song Xin-Ming, Chen Zhi-Hui, Ren Xue-Qun, Xu Kai-Wu, Jing Hong, He Yu-Long: XRCC2 as a predictive biomarker for radioresistance in locally advanced rectal cancer patients undergoing preoperative radiotherapy. Oncotarget 2015, 6, 32193. <https://doi.org/10.18632/oncotarget.4975>